Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment

Smita P. Kakad^* , Yash R. Bharati, Sanjay J. Kshirsagar , Neelam Dashputre, Anjali Tajanpure, Rani S. Kankate , Pratibha Maurya and Shalaka Dhikale

Department of Pharmaceutics, MET Institute of Pharmacy, Savitribai Phule Pune University, Adgaon, Nashik, Maharashtra, India

Corresponding Author E-mail: smitadarade87@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/3207

ABSTRACT: Background: This research was aimed with the development of antipsychotic drug delivery for olfactory administration which could deliver drug to the brain. Amisulpride is a psychoactive drug that belongs to the benzamide derivatives class. It enhances dopaminergic neurotransmission by inhibiting presynaptic dopamine D2/D3 auto receptors selectively at lower dosages. Method: The nanosuspension was prepared by media milling technique for nose to brain delivery. The nose to brain delivery developed an effective route to bypass the BBB and deliver the drug to the brain. Factorial design was used for the designing and optimizing formulation based on various process and formulation factors. The optimized batch further analyzed to determine particle size, PDI, zeta potential, and drug content. With appropriate selection of process parameters like speed and bead amount. The media milling method is one of the effective methodology to reduce particle size and with the help of stabilizers nanoparticles could be stabilised. Result: The average particle size range of nanosuspension batch was observed 100-150 nm with a polydispersity index of 0.0927, Zeta potential +39.14 mV and drug content 88.12 ± 2 %. Conclusion: Intranasal administration is a promising alternative for bypassing the blood-brain barrier, reducing the adverse effects, and lowering the doses.

KEYWORDS: Amisulpride; Antipsychotic; Brain Targeting; Media Mill; Nanosuspension

[ HTML Full Text]